Recruiting

Who we are

  • April 5, 2022
    Avelumab Combined With Cetuximab and Irinotecan for Treatment Refractory Metastatic Colorectal Microsatellite Stable Cancer
  • January 1, 1970
    A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
  • January 1, 1970
    Cadonilimab Combined With Regorafenib as A Third-line Treatment in Patients With MSS CRLM
  • January 1, 1970
    Regorafenib and Sintilimab in Combination With Electroacupuncture in MSS CRC
  • January 1, 1970
    A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
  • January 1, 1970
    Isunakinra Alone and in Combination with Pembrolizumab in Patients with Colorectal Cancer (MSS)